All Stories

  1. In-Vitro Effects of Perfluorooctanoic Acid on Human Sperm Function: What Are the Clinical Consequences?
  2. Impact of COVID-19 on testicular function: a systematic review and meta-analysis
  3. The Role of Irisin throughout Women’s Life Span
  4. Alpha-Lipoic Acid Reduces Cell Growth, Inhibits Autophagy, and Counteracts Prostate Cancer Cell Migration and Invasion: Evidence from In Vitro Studies
  5. Relationship between Iron Deficiency and Thyroid Function: A Systematic Review and Meta-Analysis
  6. Relationship between degree of methylation of sperm long interspersed nuclear element-1 (LINE-1) gene and alteration of sperm parameters and age: a meta-regression analysis
  7. Investigational follicle-stimulating hormone receptor agonists for male infertility therapy
  8. Anti-Dyslipidemic and Anti-Diabetic Properties of Corosolic Acid: A Narrative Review
  9. Impact of COVID-19 on Fetal Outcomes in Pregnant Women: A Systematic Review and Meta-Analysis
  10. Insulin-like Growth Factor 1, Growth Hormone, and Anti-Müllerian Hormone Receptors Are Differentially Expressed during GnRH Neuron Development
  11. Red Wine and Sexual Function in Men: An Original Point of View
  12. Mechanisms Suggesting a Relationship between Vitamin D and Erectile Dysfunction: An Overview
  13. Productivity Index in Clinical Andrology: Research Directions on High-Impact Topics and in Particular on Male Infertility
  14. Genetic Analysis of Patients with Congenital Hypogonadotropic Hypogonadism: A Case Series
  15. H19 Sperm Methylation in Male Infertility: A Systematic Review and Meta-Analysis
  16. Effects of Follicle-Stimulating Hormone on Human Sperm Motility In Vitro
  17. The Impact of a Very Short Abstinence Period on Assisted Reproductive Technique Outcomes: A Systematic Review and Meta-Analysis
  18. Sexual and Reproductive Outcomes in Obese Fertile Men with Functional Hypogonadism after Treatment with Liraglutide: Preliminary Results
  19. Assisted Reproductive Technology without Embryo Discarding or Freezing in Women ≥40 Years: A 5-Year Retrospective Study at a Single Center in Italy
  20. The Renaissance of Male Infertility Management in the Golden Age of Andrology
  21. Is It Time for Andrology and Endocrinology Professionals in Assisted Reproduction Centers?
  22. Artificial Intelligence in Andrology: From Semen Analysis to Image Diagnostics
  23. Sperm Mesoderm Specific Transcript Gene Methylation Status in Infertile Patients: A Systematic Review and Meta-Analysis
  24. Reply to Ducreux, B.; Fauque, P. Comment on “Cannarella et al. DNA Methylation in Offspring Conceived after Assisted Reproductive Techniques: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022, 11, 5056”
  25. The Impact of a Very Short Abstinence Period on Conventional Sperm Parameters and Sperm DNA Fragmentation: A Systematic Review and Meta-Analysis
  26. The IGF1/FSH Ratio Correlates with Sperm Count and Testicular Volume
  27. Does the Ketogenic Diet Improve the Quality of Ovarian Function in Obese Women?
  28. The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: An overview on male genital tract ultrasound reference ranges
  29. Resistance to Thyroid Hormones: A Case-Series Study
  30. Effects of Slow-Acting Metformin Treatment on the Hormonal and Morphological Thyroid Profile in Patients with Insulin Resistance
  31. The Possible Role of SARS-CoV-2 in Male Fertility: A Narrative Review
  32. DNA Methylation in Offspring Conceived after Assisted Reproductive Techniques: A Systematic Review and Meta-Analysis
  33. The Use of Ellagic Acid and Annona Muricata Improves Semen Quality in Men with High-Risk Papillomavirus Infection
  34. The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: Prostate‐vesicular transrectal ultrasound reference ranges and associations with clinical, seminal and biochemical characteristics
  35. Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA
  36. Physical Examination for Endocrine Diseases: Does It Still Play a Role?
  37. Advances in non-hormonal pharmacotherapy for the treatment of male infertility: the role of inositols
  38. Relationship between Varicocele and Male Hypogonadism: A Review with Meta-Analysis
  39. Is Chronic Varicocele a Risk Factor for Secondary Hyperparathyroidism?
  40. Obesity and Male Reproduction: Do Sirtuins Play a Role?
  41. Impact of seminal low-risk human papillomavirus infection on sperm parameters of adult men
  42. Analysis of 29 Targeted Genes for Non-Obstructive Azoospermia: The Relationship between Genetic Testing and Testicular Histology
  43. Globozoospermia: A Case Report and Systematic Review of Literature
  44. Molecular Mechanisms Underlying the Relationship between Obesity and Male Infertility
  45. Complete Androgen Insensitivity Syndrome: From the Relevance of an Accurate Genetic Diagnosis to the Challenge of Clinical Management. A Case Report
  46. Does a Very Short Length of Abstinence Improve Assisted Reproductive Technique Outcomes in Infertile Patients with Severe Oligo-Asthenozoospermia?
  47. Erectile Dysfunction in Diabetic Patients: From Etiology to Management
  48. Effects of Selenium Supplementation on Sperm Parameters and DNA-Fragmentation Rate in Patients with Chronic Autoimmune Thyroiditis
  49. Retrospective Monocentric Clinical Study on Male Infertility: Comparison between Two Different Therapeutic Schemes Using Follicle-Stimulating Hormone
  50. Relevance of sperm imprinted gene methylation on assisted reproductive technique outcomes and pregnancy loss: a systematic review
  51. Coenzyme Q10, oxidative stress markers, and sperm DNA damage in men with idiopathic oligoasthenoteratospermia
  52. Ultrasound aspects of symptomatic versus asymptomatic forms of male accessory gland inflammation
  53. Is there a role for glucagon‐like peptide‐1 receptor agonists in the treatment of male infertility?
  54. Ultrasound evaluation of patients with male accessory gland inflammation: a pictorial review
  55. The Role of Resveratrol in Human Male Fertility
  56. The Role of Resveratrol Administration in Human Obesity
  57. Temporal Trend of Conventional Sperm Parameters in a Sicilian Population in the Decade 2011–2020
  58. Anti-Müllerian Hormone, Growth Hormone, and Insulin-Like Growth Factor 1 Modulate the Migratory and Secretory Patterns of GnRH Neurons
  59. The Relationship between Seminal Fluid Hyperviscosity and Oxidative Stress: A Systematic Review
  60. The Investigative Role of Statins in Ameliorating Lower Urinary Tract Symptoms (LUTS): A Systematic Review
  61. Differences in Penile Hemodynamic Profiles in Patients with Erectile Dysfunction and Anxiety
  62. Novel Insights on the Role of the Human Sperm Proteome
  63. Seminal Plasma Proteomic Biomarkers of Oxidative Stress
  64. The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: scrotal ultrasound reference ranges and associations with clinical, seminal and biochemical characteristics
  65. Clinical Evaluation of a Custom Gene Panel as a Tool for Precision Male Infertility Diagnosis by Next-Generation Sequencing
  66. Seminal Plasma Transcriptome and Proteome: Towards a Molecular Approach in the Diagnosis of Idiopathic Male Infertility
  67. Effectiveness of a Very Low Calorie Ketogenic Diet on Testicular Function in Overweight/Obese Men
  68. Sexual Dysfunction in Diabetic Women: An Update on Current Knowledge
  69. Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects
  70. Mean Platelet Volume as a Marker of Vasculogenic Erectile Dysfunction and Future Cardiovascular Risk
  71. Mitochondrial Membrane Potential Predicts 4-Hour Sperm Motility
  72. Erectile Dysfunction after Kidney Transplantation
  73. Follicle-Stimulating Hormone Treatment and Male Idiopathic Infertility: Effects on Sperm Parameters and Oxidative Stress Indices according to FSHR c. 2039 A/G and c. -29 G/A Genotypes
  74. Is There an Association Between Vitamin D Deficiency and Erectile Dysfunction? A Systematic Review and Meta-Analysis
  75. Use of Biosimilar Follicle-Stimulating Hormone in Asthenozoospermic Infertile Patients: A Multicentric Study
  76. D-Chiro-Inositol Improves Sperm Mitochondrial Membrane Potential: In Vitro Evidence
  77. The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: clinical, seminal and biochemical characteristics
  78. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
  79. Disorders of Puberty: Endocrinology of the Pre-Pubertal Testis
  80. Is There a Role for Levo-Thyroxine for the Treatment of Arterial Erectile Dysfunction? The Clinical Relevance of the Mean Platelet Volume
  81. Molecular Biology of Spermatogenesis: Novel Targets of Apparently Idiopathic Male Infertility
  82. Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?
  83. From Spermiogram to Bio-Functional Sperm Parameters: When and Why Request Them?
  84. Evaluation of Sperm Mitochondrial Function: A Key Organelle for Sperm Motility
  85. Coenzyme Q10 Improves Sperm Parameters, Oxidative Stress Markers and Sperm DNA Fragmentation in Infertile Patients with Idiopathic Oligoasthenozoospermia
  86. Evaluation of seminal fluid leukocyte subpopulations in patients with varicocele
  87. Combined Effects of the FSHR 2039 A/G and FSHR -29 G/A Polymorphisms on Male Reproductive Parameters
  88. Use of follicle‐stimulating hormone (FSH) for the male partner of idiopathic infertile couples in Italy: Results from a multicentre, observational, clinical practice survey
  89. Testicular Function of Childhood Cancer Survivors: Who Is Worse?
  90. Evaluation of the Mistakes in Self-Diagnosis of Sexual Dysfunctions in 11,000 Male Outpatients: A Real-Life Study in An Andrology Clinic
  91. Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly
  92. Management and Treatment of Varicocele in Children and Adolescents: An Endocrinologic Perspective
  93. Effects of Insulin on Porcine Neonatal Sertoli Cell Responsiveness to FSH In Vitro
  94. Effects of GH and IGF1 on Basal and FSH-Modulated Porcine Sertoli Cells In-Vitro
  95. Accuracy of the Low-Dose ACTH Stimulation Test for Adrenal Insufficiency Diagnosis: A Re-Assessment of the Cut-Off Value
  96. Early male aging or poor clinical consideration for males in IVF centers? An original study
  97. Thyroid Hormones and Spermatozoa: In VitroEffects on Sperm Mitochondria, Viability and DNA Integrity
  98. Effects of the selective estrogen receptor modulators for the treatment of male infertility: a systematic review and meta-analysis
  99. Substance Abuse and Male Hypogonadism
  100. EAA clinical practice guidelines—gynecomastia evaluation and management
  101. Early Identification of Isolated Sertoli Cell Dysfunction in Prepubertal and Transition Age: Is It Time?
  102. Poor Efficacy of L-Acetylcarnitine in the Treatment of Asthenozoospermia in Patients with Type 1 Diabetes
  103. The IGF1 Receptor Is Involved in Follicle-Stimulating Hormone Signaling in Porcine Neonatal Sertoli Cells
  104. Environment and Male Fertility: Effects of Benzo-α-Pyrene and Resveratrol on Human Sperm Function In Vitro
  105. FSH therapy for idiopathic male infertility: four schemes are better than one
  106. IGF2 and IGF1R mRNAs Are Detectable in Human Spermatozoa
  107. Thyroid Prostate Axis. Does It Really Exist?
  108. Urogenital infections in patients with diabetes mellitus: Beyond the conventional aspects
  109. Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis
  110. Current and emerging medical therapeutic agents for idiopathic male infertility
  111. The advantages of proteomic investigation in the management of male accessory gland infection: A response to Grande et al
  112. Nicotine Receptors as a Possible Marker for Smoking-related Sperm Damage
  113. Epigenetics of Male Fertility: Effects on Assisted Reproductive Techniques
  114. Dual-release hydrocortisone treatment: glycometabolic profile and health-related quality of life
  115. IGF1 is involved in testicular differentiation and function
  116. Male accessory gland inflammation, infertility, and sexual dysfunctions: a practical approach to diagnosis and therapy
  117. Chromosome 15 structural abnormalities: effect on IGF1R gene expression and function
  118. The importance of the functional network between endothelial microparticles and late endothelial progenitor cells for understanding the physiological aspects of this new vascular repair system
  119. PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution
  120. Conservative Nonhormonal Options for the Treatment of Male Infertility: Antibiotics, Anti-Inflammatory Drugs, and Antioxidants
  121. Chronic Administration of Tadalafil Improves the Symptoms of Patients with Amicrobic MAGI: An Open Study
  122. HumanPapilloma VirusInfection in Patients with Male Accessory Gland Infection: Usefulness of the Ultrasound Evaluation
  123. Asthenozoospermia and membrane remodeling enzymes: a new role for phospholipase A2
  124. In vitro effects of aspartic acid, coenzyme Q10 and zinc on sperm function
  125. Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study
  126. Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms
  127. Modulation of central glucocorticoid receptors in short- and long-term experimental hyperthyroidism
  128. Prevalence of Intratubular Germ Cell Neoplasia and Multifocality in Testicular Germ Cell Tumors ≤ 2 cm: Relationship With Other Pathological Features
  129. Expression of Phosphodiesterase 4B cAMP-Specific Gene in Subjects With Cryptorchidism and Down's Syndrome
  130. Left spermatic vein retrograde sclerosis: comparison between sclerosant agent injection through a diagnostic catheter versus through an occluding balloon catheter
  131. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study
  132. Insulin Resistance Is an Independent Predictor of Severe Lower Urinary Tract Symptoms and of Erectile Dysfunction: Results from a Cross‐Sectional Study
  133. PARP-1 and CASP3 genes are up-regulated in LNCaP and PC-3 prostate cancer cell lines
  134. The gonadal function in obese adolescents: review
  135. PD25-09 NON ALCOHOLIC FATTY LIVER DISEASE IS AN INDEPENDENT PREDICTOR OF MODERATE-SEVERE LOWER URINARY TRACT SYMPTOMS IN METABOLIC SYNDROME PATIENTS: RESULTS FROM A CROSS-SECTIONAL STUDY
  136. PD25-06 INSULIN RESISTANCE IS SIGNIFICANTLY ASSOCIATED WITH SEVERITY OF LOWER URINARY TRACT SYMPTOMS AND WITH ERECTILE DYSFUNCTION: RESULTS FROM A CROSS-SECTIONAL STUDY
  137. New perspectives for prostate cancer treatment:in vitroinhibition of LNCaP and PC3 cell proliferation by amnion-derived mesenchymal stromal cells conditioned media
  138. Reduced Seminal Concentration of CD45pos Cells after Follicle-Stimulating Hormone Treatment in Selected Patients with Idiopathic Oligoasthenoteratozoospermia
  139. Association study of COX-2 (PTGS2) –765 G/C promoter polymorphism by pyrosequencing in Sicilian patients with Alzheimer’s disease
  140. Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in prostate cancer cell lines
  141. CASP3 protein expression by flow cytometry in Down’s syndrome subjects
  142. Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?
  143. Markers of semen inflammation: supplementary semen analysis?
  144. Erratum to: CASP3 and LDOC-1 gene expression in a patient with carcinoma in the hairy part of the head skin and Alzheimer disease
  145. CASP3 and LDOC-1 gene expression in a patient with carcinoma in the hairy part of the head skin and Alzheimer disease
  146. Male sexuality, fertility and smoking
  147. Endothelial progenitor cells and erectile dysfunction: a brief review on diagnostic significance and summary of our experience
  148. 1234 PREDICTIVE FACTORS OF ERECTILE DYSFUNCTION AFTER TURP IN POTENT PATIENTS
  149. Arterial erectile dysfunction: Different severities of endothelial apoptosis between diabetic patients “responders” and “non responders” to sildenafil
  150. LDOC-1 and PARP-1 mRNA expression in leukocytes of father and son with cutaneous malignant melanoma
  151. Erratum to: Effects of experimentally induced hyperthyroidism on central hypothalamic–pituitary–adrenal axis function in rats: in vitro and in situ studies
  152. Best Practice Guidelines for the Use of Antioxidants in Male Infertility
  153. Best Practice Guidelines for the Use of Antioxidants
  154. Relationship between Testicular Volume and Conventional or Nonconventional Sperm Parameters
  155. Effects of Male Accessory Gland Infection on Sperm Parameters
  156. Does alcohol have any effect on male reproductive function? A review of literature
  157. Follicle-stimulating hormone treatment in normogonadotropic infertile men
  158. Persistence of ultrasound alterations after antibiotic treatment with levofloxacin in patients with male accessory gland infection
  159. Effects of experimentally induced hyperthyroidism on central hypothalamic–pituitary–adrenal axis function in rats: in vitro and in situ studies
  160. KIF21A mRNA expression in patients with Down syndrome
  161. P-429
  162. P-432
  163. P-431
  164. SPAG5 mRNA is over-expressed in peripheral blood leukocytes of patients with Down’s syndrome and cryptorchidism
  165. Effects of short- and long-duration hypothyroidism on hypothalamic–pituitary–adrenal axis function in rats: In vitro and in situ studies
  166. Myoinositol: Does It Improve Sperm Mitochondrial Function and Sperm Motility?
  167. Two Proapoptotic Genes Are Downregulated in a Patient With Melanoma and Repeated In-Transit Metastases
  168. Prevalence ofUreaplasma urealyticumandMycoplasma hominisinfection in unselected infertile men
  169. Expression of LDOC1 mRNA in leucocytes of patients with Down’s syndrome
  170. Best Practice Guidelines for the Use of Antioxidants
  171. Oxidative Stress and Infection
  172. Sperm DNA damage in patients with chronic viral C hepatitis
  173. Bone Demineralization in Postmenopausal Women: Role of Anamnestic Risk Factors
  174. Three apoptotic genes are upregulated in a patient with Alzheimer’s disease and well-differentiated squamous cell carcinoma
  175. Aerobic physical activity improves endothelial function in the middle-aged patients with erectile dysfunction
  176. Ultrasound characterization of the seminal vesicles in infertile patients with type 2 diabetes mellitus
  177. Seminal vesicles and diabetic neuropathy: ultrasound evaluation in patients with couple infertility and different levels of glycaemic control
  178. PARP1 and CASP3 gene expression in a patient with multiple head and neck squamous cell carcinoma and Parkinson disease
  179. High Frequency of Chronic Bacterial and Non-Inflammatory Prostatitis in Infertile Patients with Prostatitis Syndrome Plus Irritable Bowel Syndrome
  180. Over expression of LDOC1 and PARP1, two pro-apoptotic genes, in a patient with cryptorchidism and DiGeorge anomaly
  181. Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: effects of androgen replacement therapy
  182. Effects of Male Accessory Gland Infection on Sperm Parameters
  183. Chlamydia trachomatisPrevalence in Unselected Infertile Couples
  184. Endothelial Antioxidant Administration Ameliorates the Erectile Response to PDE5 Regardless of the Extension of the Atherosclerotic Process
  185. Oxidative stress and medical antioxidant treatment in male infertility
  186. Cigarette smoke extract immobilizes human spermatozoa and induces sperm apoptosis
  187. A High Percentage of Skin Melanoma Cells Expresses SPANX Proteins
  188. Candida albicans experimental infection: effects on human sperm motility, mitochondrial membrane potential and apoptosis
  189. Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and cardiovascular comorbidities
  190. Sexual Dysfunction in Chronic Hepatitis C Virus Patients Treated with Interferon Alpha and Ribavirin
  191. Transrectal ultrasonography in infertile patients with persistently elevated bacteriospermia
  192. SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Sicilian patients with melanoma
  193. Effects of Tumour Necrosis Factor-α on Human Sperm Motility and Apoptosis
  194. Effects of Tumour Necrosis Factor-α on Human Sperm Motility and Apoptosis
  195. Expression of SpanX mRNA in testicular germ cell tumors
  196. Quantitative evaluation of partial deletions of the DAZ gene cluster
  197. Expression of SpanX proteins in normal testes and in testicular germ cell tumours
  198. Gene expression in mouse spermatogenesis during ontogenesis
  199. Low total normal motile count values are associated with increased sperm disomy and diploidy rates in infertile patients
  200. Genetics of polycystic ovarian syndrome
  201. Human follicular fluid stimulates the sperm acrosome reaction by interacting with the γ-aminobutyric acid receptors
  202. Normal expression of isoforms activating cyclic adenosine monophosphate responsive element modulator in patients with spermatid maturation arrest
  203. Expression of SPANX proteins in human-ejaculated spermatozoa and sperm precursors
  204. Inhibition of oocyte fertilization by assisted reproductive techniques and increased sperm DNA fragmentation in the presence of Candida albicans: a case report
  205. Antioxidant treatment with carnitines is effective in infertile patients with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after treatment with nonsteroidal anti-inflammatory compounds
  206. Lower sperm aneuploidy rate is associated with a higher pregnancy rate in unselected patients undergoing intracytoplasmic sperm injection
  207. Chromosome analysis of epididymal and testicular spermatozoa in patients with azoospermia
  208. Gallbladder and gastric emptying: relationship to cholecystokininemia in diabetics
  209. Cloning and Expression of Activator of CREM in Testis in Human Testicular Tissue
  210. Genetic, andrological and clinical characteristics of patients with congenital bilateral absence of the vas deferens
  211. Increased ACTH and cortisol secretion after interleukin-1α injection in the common marmoset (Callithrix jacchus jacchus)
  212. Epididymal and testicular sperm retrieval in azoospermic patients and the outcome of intracytoplasmic sperm injection in relation to the etiology of azoospermia
  213. Effects of cancer and anti-neoplastic treatment on the human testicular function
  214. MACROPHAGE-DERIVED CYTOKINES IN THE FOLLICULAR FLUIDS OF WOMEN WITH INFERTILITY DUE TO IMMUNOLOGICAL CAUSES. ELEVATED LEVELS OF INTERLEUKIN 6 AND LOW LEVELS OF GRANULOCYTE–MACROPHAGE COLONY-STIMULATING FACTOR
  215. Mechanisms of Stress on Reproduction: Evidence for a Complex Intra-Hypothalamic Circuit
  216. Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus
  217. Identification, Characterization, and Biological Activity of Endothelin Receptors in Human Ovary1
  218. The biobehavioral consequences of psychogenic stress in a small, social primate (Callithrix jacchus jacchus)
  219. Effects of Early Parenting on Growth and Development in a Small Primate
  220. The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy
  221. Adenylate-Cyclase-Dependent Pituitary Adrenocorticotropin Secretion Is Defective in the Inflammatory-Disease-Susceptible Lewis Rat
  222. Effects of γ-aminobutyric acid on human sperm motility and hyperactivation
  223. Neurotransmitter Regulation of the Hypothalamic Corticotropin-Releasing Hormone Neuron
  224. Measurements of hormonal peptides in the bronchoalveolar fluid as tumor markers of lung cancer
  225. Effects of Rat Prolactin on Gonadotropin-Releasing Hormone Secretion by the Explanted Male Rat Hypothalamus
  226. Effects of Cholecystokinin Octapeptide on the Hypothalamic-Pituitary-Adrenal Axis Function and on Vasopressin, Prolactin and Growth Hormone Release in Humans
  227. Limited clinical usefulness of plasma corticotropin-releasing hormone, adrenocorticotropin and ß-endorphin measurements as markers of lung cancer.
  228. Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery
  229. Effect of various neurotransmitters and neuropeptides on the release of corticotropin-releasing hormone from the rat cortex in vitro
  230. Neurotransmitter-lnduced Hypothalamic-Pituitary-Adrenal Axis Responsiveness Is Defective in Inflammatory Disease-Susceptible Lewis Rats: In vivo and in vitro Studies Suggesting Globally Defective Hypothalamic Secretion of Corticotropin-Releasing Hormone
  231. Effects of Short and Long Duration Hypothyroidism and Hyperthyroidism on the Plasma Adrenocorticotropin and Corticosterone Responses to Ovine Corticotropin-Releasing Hormone in Rats*
  232. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat
  233. Role of peripherally infused angiotensin II on the human hypothalamic–pituitary–adrenal axis
  234. Prolactin Stimulates Rat Hypothalamic Corticotropin-Releasing Hormone and Pituitary Adrenocorticotropin Secretion in vitro
  235. Circadian Patterns of Plasma Immunoreactive Corticotropin, Beta-Endorphin, Corticosterone and Prolactin after Immunoneutralization of Corticotropin-Releasing Hormone
  236. β-Endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action
  237. Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH
  238. Recovery of the Rat Hypothalamic-Pituitary-Adrenal Axis after Discontinuation of Prolonged Treatment with the Synthetic Glucocorticoid Agonist Dexamethasone
  239. Interactions between Tumor Necrosis Factor-α, Hypothalamic Corticotropin-Releasing Hormone, and Adrenocorticotropin Secretion in the Rat*
  240. In Vitroandin VivoEffects of the Triazolobenzodiazepine Alprazolam on Hypothalamic Pituitary-Adrenal Function: Pharmacological and Clinical Implications*
  241. Mechanisms of Serotonin Receptor Agonist-Induced Activation of the Hypothalamic-Pituitary-Adrenal Axis in the Rat
  242. lntra- and Inter-Individual Variability in Growth Hormone Responses to Growth Hormone-Releasing Hormone
  243. Rat hypothalamic corticotropin-releasing hormone secretion is stimulated by interleukin-1 in an eicosanoid-dependent manner
  244. Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro
  245. The Muscarinic Cholinergic Agonist Arecoline Stimulates the Rat Hypothalamic-Pituitary-Adrenal Axis Through a Centrally-Mediated Corticotropin-Releasing Hormone-Dependent Mechanism
  246. The Alkyl-Ether Phospholipid Platelet-Activating Factor is a Stimulator of the Hypothalamic-Pituitary-Adrenal Axis in the Rat*
  247. Delayed effects of chronic cortisol treatment on brain and plasma concentrations of corticotropin (ACTH) and β-endorphin
  248. Long-Term Cortisol Treatment Impairs Behavioral and Neuroendocrine Responses to 5-HT1 Agonists in the Rat
  249. Arachidonic Acid Metabolites Modulate Rat Hypothalamic Corticotropin-Releasing Hormone Secretion in vitro
  250. Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami
  251. Sympathoadrenomedullary Inhibition by Chronic Glucocorticoid Treatment in Conscious Rats
  252. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro
  253. Interaction of Epidermal Growth Factor With the Hypothalamic-Pituitary-Adrenal Axis: Potential Physiologic Relevance*
  254. Effect of Cholinergic Agonists and Antagonists on Rat Hypothalamic Corticotropin-Releasing Hormone Secretion in vitro
  255. Dynamics of Plasma Gonadotropin and Sex Steroid Release in Polycystic Ovarian Disease After Pituitary Ovarian Inhibition with an Analog of Gonadotropin-Releasing Hormone*